Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,252,800
+$81,756 QoQ
Shares Held
18,760
-3.2% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#239
of 1,045 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $164,155,372 across 29 Diagnostics & Research names. LH ranks #11 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
85,023 | $42,627,131 | |
| 2 | DHR |
Danaher Corp /De/
|
144,142 | $27,456,168 | |
| 3 | ILMN |
Illumina, Inc.
|
72,858 | $12,810,622 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
20,659 | $10,875,723 | |
| 5 | A |
Agilent Technologies, Inc.
|
64,648 | $8,587,193 | |
| 6 | WAT |
Waters Corp /De/
|
22,466 | $8,425,648 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
38,172 | $7,375,593 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
11,779 | $6,238,040 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,252,800 | 18,760 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,171,044 | 19,381 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,988,247 | 19,883 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $5,921,473 | 20,628 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,597,763 | 21,324 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $5,043,475 | 21,670 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $5,078,291 | 22,145 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,879,462 | 21,834 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,574,497 | 22,478 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||